- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-6362
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Gout, flares, and allopurinol use: a population-based study ; volume:21 ; number:1 ; day:31 ; month:5 ; year:2019 ; pages:1-8 ; date:12.2019
Arthritis Research & Therapy ; 21, Heft 1 (31.5.2019), 1-8, 12.2019
- Creator
-
Proudman, Charlotte
Lester, Susan E.
Gonzalez-Chica, David A.
Gill, Tiffany K.
Dalbeth, Nicola
Hill, Catherine L.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13075-019-1918-7
- URN
-
urn:nbn:de:101:1-2019112719360321309224
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:55 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Proudman, Charlotte
- Lester, Susan E.
- Gonzalez-Chica, David A.
- Gill, Tiffany K.
- Dalbeth, Nicola
- Hill, Catherine L.
- SpringerLink (Online service)
Other Objects (12)
Allopurinol and prostate cancer survival in a Finnish population-based cohort
Hyperuricaemia, gout and allopurinol in the CKD Queensland registry
Cohort study investigating gout flares and management in UK general practice
ABCG2 gene polymorphism rs2231142 is associated with gout comorbidities but not allopurinol response in primary gout patients of a Chinese Han male population
Fluctuation and change of serum urate levels and flares in gout: results from the NOR-Gout study
Physical activity measured using wearable activity tracking devices associated with gout flares
Optimizing pulsatile release of febuxostat for managing gout flares: a chronotherapeutic approach
African American patients with gout: efficacy and safety of febuxostat vs allopurinol
The challenges of gout flare reporting: mapping flares during a randomized controlled trial
Patient and clinical characteristics associated with gout flares in an integrated healthcare system
Transdermal delivery of allopurinol-loaded nanostructured lipid carrier in the treatment of gout
Effect of omega-three supplementation on serum urate and gout flares in people with gout; a pilot randomized trial
Allopurinol and prostate cancer survival in a Finnish population-based cohort
Hyperuricaemia, gout and allopurinol in the CKD Queensland registry
Cohort study investigating gout flares and management in UK general practice
ABCG2 gene polymorphism rs2231142 is associated with gout comorbidities but not allopurinol response in primary gout patients of a Chinese Han male population
Fluctuation and change of serum urate levels and flares in gout: results from the NOR-Gout study
Physical activity measured using wearable activity tracking devices associated with gout flares
Optimizing pulsatile release of febuxostat for managing gout flares: a chronotherapeutic approach
African American patients with gout: efficacy and safety of febuxostat vs allopurinol
The challenges of gout flare reporting: mapping flares during a randomized controlled trial
Patient and clinical characteristics associated with gout flares in an integrated healthcare system
Transdermal delivery of allopurinol-loaded nanostructured lipid carrier in the treatment of gout
Effect of omega-three supplementation on serum urate and gout flares in people with gout; a pilot randomized trial
Allopurinol and prostate cancer survival in a Finnish population-based cohort
Hyperuricaemia, gout and allopurinol in the CKD Queensland registry
Cohort study investigating gout flares and management in UK general practice
ABCG2 gene polymorphism rs2231142 is associated with gout comorbidities but not allopurinol response in primary gout patients of a Chinese Han male population
Fluctuation and change of serum urate levels and flares in gout: results from the NOR-Gout study
Physical activity measured using wearable activity tracking devices associated with gout flares
Optimizing pulsatile release of febuxostat for managing gout flares: a chronotherapeutic approach
African American patients with gout: efficacy and safety of febuxostat vs allopurinol
The challenges of gout flare reporting: mapping flares during a randomized controlled trial
Patient and clinical characteristics associated with gout flares in an integrated healthcare system
Transdermal delivery of allopurinol-loaded nanostructured lipid carrier in the treatment of gout